SOME PHYSIOLOGICAL CHARACTERISTICS OF NEOMYCIN AND KANAMYCIN-RESISTANT STRAINS OF STAPHYLOCOCCUS AUREUS

Insights

Hospital-origin Staphylococcus aureus strains showed resistance to common antibiotics. A subset also exhibited neomycin and kanamycin resistance, linked to specific physiological markers and phage susceptibility.

Area of Science:

  • Microbiology
  • Clinical Infectious Diseases

Background:

  • Hospital-acquired Staphylococcus aureus infections pose significant treatment challenges due to antibiotic resistance.
  • Penicillin, streptomycin, and tetracycline resistance are common in clinical isolates.

Purpose of the Study:

  • To investigate the characteristics of Staphylococcus aureus strains exhibiting resistance to multiple antibiotics, including neomycin and kanamycin.
  • To explore the relationship between antibiotic resistance patterns and physiological markers in these strains.

Main Methods:

  • Phenotypic characterization of 552 hospital-origin Staphylococcus aureus strains.
  • Assessment of resistance to penicillin, streptomycin, tetracycline, neomycin, and kanamycin.
  • Evaluation of pigment production, beta-lysin, fibrinolytic, and proteolytic activity.
  • Phage susceptibility testing.

Main Results:

  • All 552 strains were resistant to penicillin, streptomycin, and tetracycline.
  • 298 strains displayed additional resistance to neomycin and kanamycin.
  • Neomycin/kanamycin resistance correlated with pigment production, beta-lysin presence, absence of fibrinolytic/proteolytic activity, and specific phage susceptibility patterns.

Conclusions:

  • Physiological markers can be associated with multidrug resistance in Staphylococcus aureus.
  • Phage typing may have limitations in characterizing certain resistant strains.
  • Understanding these markers is crucial for managing the emergence of antibiotic-resistant staphylococci.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...